Please enable JavaScript.
Coggle requires JavaScript to display documents.
THALASAEMIA, b THALASSAEMIA MAJOR - Coggle Diagram
THALASAEMIA
-
- Reduced synthesis of one or more of the globin polypeptide chains
- Quantitative abnormalities of polypeptide globin chain synthesis
- First identified in the Mediterranean, also called Mediterranean anaemia
- ‘thala’ means sea in Greek
- 35 million have b Thalassaemia major
-
b THALASSAEMIA MAJOR
CLINICAL FEATURES
-
LABORATORY FINDINGS
-
- sever microcytic hypochromic red cell,
- anisopoikilocytosis,
- basophilic stippling,
- prescence of target cells,
- tear drop cells and
- normoblasts
-
-
-
-
- Decreased osmotic fragility
- 1 more item...
PRINCIPLES OF TREATMENT
- Anaemia: regular blood transfusion (4-6 weeks) to maintain Hb above
8g/dL
- Splenectomy is beneficial in children over
6 years
- Bone marrow transplantation from
HLA-matched donor provides stem cells,
- done at early stage before end organ damage
-
- Mediterranean or Cooley’s anaemia
- is the most common form of
- congenital haemolytic anaemia
- Homozygous state
- with complete absence of b-chain synthesis
- or only small amounts of b-chains are formed
- Resulting in excessive formation of
- alternate haemoglobins
- HbF and HbA2